Krane Funds Advisors’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-1,238
Closed -$101K 307
2021
Q2
$101K Sell
1,238
-4,565
-79% -$373K ﹤0.01% 280
2021
Q1
$457K Sell
5,803
-224
-4% -$17.6K 0.02% 185
2020
Q4
$515K Buy
6,027
+980
+19% +$81K 0.02% 125
2020
Q3
$389K Sell
5,047
-29
-0.6% -$2.21K 0.02% 145
2020
Q2
$372K Buy
+5,076
New +$361K 0.02% 181
2019
Q4
Sell
-7,054
Closed -$519K 232
2019
Q3
$519K Buy
7,054
+6,708
+1,939% +$487K 0.04% 158
2019
Q2
$25K Buy
+346
New +$24.6K ﹤0.01% 143

Other funds holding CL

Krane Funds Advisors's CL Position: Q3 2021 in Review

Krane Funds Advisors sold out of Colgate-Palmolive (CL) in Q3 2021, closing a stake of 1,238 shares — an estimated $101K sold.

Krane Funds Advisors first reported a position in CL in Q2 2019 and held it in 7 quarters. The position peaked at $519K in Q3 2019. 1,583 funds tracked by Wall St. Rank hold CL as of Q3 2021.

  • Krane Funds Advisors reported no remaining Colgate-Palmolive position as of Q3 2021 after selling out during the quarter.
  • Krane Funds Advisors sold 1,238 Colgate-Palmolive shares in Q3 2021, an estimated $101K.
  • Krane Funds Advisors first reported a position in Colgate-Palmolive in Q2 2019 and held it in 7 quarters.
  • Krane Funds Advisors's Colgate-Palmolive position peaked at $519K in Q3 2019.
  • 1,583 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2021.

Based on Krane Funds Advisors's 13F filing for Q3 2021, filed 12 Nov 2021.